Metabolic Control and Patient Well-being in Phenylketonuria: do Guidelines Make a Difference?

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

Treatment of PKU implies for most patients that with strict adherence to dietary treatment they can achieve excellent neurocognitive outcome. Dietary treatment, though, is hard to comply to every day and with every single meal. Unsurprisingly, health-related quality of life (HrQol) is negatively affected if patients have to follow a dietary regime of this kind. Adherence to treatment in PKU is very variable. Factors of significant impact on adherence to treatment and well-being in chronic disease such as self-efficacy or parenting stress have not yet been widely investigated in PKU patients. The ideal treatment prescription (and guideline) recommends as much as necessary and as little as possible, based on the best evidence available. Patients should neither be deprived of treatment options nor be exposed to overtreatment. This study investigates adherence, metabolic control, HrQol in PKU patients treated by centres which follow different guidelines

Eligibility
Participation Requirements
Sex: All
Minimum Age: 10
Healthy Volunteers: f
View:

• Parents of patients with PKU aged 10 to 18 years requiring dietary and / or pharmacological treatment according to locally applied guidelines

• Ability and willingness to answer the questionnaires and follow the study procedures

• Informed consent as documented by signature

Locations
Other Locations
Switzerland
University Childrens Hospital Zürich
RECRUITING
Zurich
Contact Information
Primary
Martina Huemer, Prof
martina.huemer@kispi.uzh.ch
+41 44 2660
Time Frame
Start Date: 2021-11-15
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 200
Related Therapeutic Areas
Sponsors
Collaborators: University Children's Hospital Basel, Insel Gruppe AG, University Hospital Bern, UChildrenVienna
Leads: University Children's Hospital, Zurich

This content was sourced from clinicaltrials.gov